| Authors: |
Stasik S; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany., Burkhard-Meier C; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Kramer M; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Middeke JM; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Oelschlaegel U; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Sockel K; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Ehninger G; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Serve H; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany., Müller-Tidow C; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Baldus CD; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany., Röllig C; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany., Bornhäuser M; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany., Platzbecker U; Department of Hematology, Cellular Therapy, and Hemostaseology, University Hospital Leipzig, Leipzig, Germany; and., Thiede C; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.; AgenDix GmbH, Dresden, Germany. |
